Smoking Gun — Covid19 Virus Confirmed in USA Before Wuhan

San Francisco CA

Description

China is Definitely Not The Virus Origin Dr Michael Heng Increasingly, more and more studies and evidence are emerging pointing to other Covid-19 virus origins as more plausible or credible alternatives to Wuhan, China, where the virus was first discovered, identified and reported to WHO (World Health Organisation). Scientists are in agreement that the place of first discovery of the virus is not necessarily its origin. The latest smoking gun is provided by the United States United States (US) National Institutes of Health (NIH). The NIH recently published a new study which analyzed more than 24,000 stored blood samples contributed by participants during the January-March 2020 period, and concluded that Covid-19 virus was present in the US as far back as December 2019, weeks before the first officially reported cases, and long before its discovery in Wuhan, China. The scientific study by the US Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America in December 2020 shows that between 13–16 December 2019, coronavirus antibodies were detected in at least 39 blood samples from the states of California, Oregon and Washington. Antibo medium.com Smoking Gun — Covid19 Virus Confirmed in USA Before Wuhan Dr Michael Heng 10-12 minutes China is Definitely Not The Virus Origin Dr Michael Heng Increasingly, more and more studies and evidence are emerging pointing to other Covid-19 virus origins as more plausible or credible alternatives to Wuhan, China, where the virus was first discovered, identified and reported to WHO (World Health Organisation). Scientists are in agreement that the place of first discovery of the virus is not necessarily its origin. The latest smoking gun is provided by the United States United States (US) National Institutes of Health (NIH). The NIH recently published a new study which analyzed more than 24,000 stored blood samples contributed by participants during the January-March 2020 period, and concluded that Covid-19 virus was present in the US as far back as December 2019, weeks before the first officially reported cases, and long before its discovery in Wuhan, China. The scientific study by the US Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America in December 2020 shows that between 13–16 December 2019, coronavirus antibodies were detected in at least 39 blood samples from the states of California, Oregon and Washington. Antibodies are formed by the human body in response to the invasion by foreign viruses. A person’s immune system develops antibodies when exposed to a pathogen like a virus to fight it off. Their presence suggests exposure to a virus. Researchers were looking for antibodies in the blood that represent undisputed evidence of coronavirus infection, and can be detected as early as two weeks after a person is first infected. The researchers say 7 study participants — three from Illinois, and one each from Massachusetts, Mississippi, Pennsylvania, and Wisconsin — were infected earlier than any Covid-19 case was originally reported in those states. They had also considered and dismissed these results to be false positives. Researchers found it noteworthy that the 7 did not live in or near New York City or Seattle, where the first wave of US Covid-19 cases were concentrated. One of the Illinois cases was infected as early as 24 December 2019, indicating that he was likely infected in late November 2019 given the antibody formative period of at least 14 days. Unlike China, and in spite of their capability and capacity in scientific expertise and technology, neither the CDC nor the US government conducted an immediate vigorous and transparent investigation into these earlier cases. The failure to detect the Covid-19 virus earlier in the Fall of 2019 may have cost millions of American lives lost to the virus. Officially, the first US infection to be identified was a traveler — a Washington state man who returned from Wuhan on 15 Jan 2020. The CDC had initially said that this was the spark that started the US Covid-19 outbreak during a 3-week window from 15 January to early February 2020. This is no longer a true and correct assessment. The new Study indicated that “… the Covid-19 virus was probably seeded in multiple places in our country,” said Associate Professor Keri Althoff of the Johns Hopkins Bloomberg School of Public Health and the Study’s lead author. This latest Study adds to numerous earlier research studies — including some done by the CDC — which suggested a small number of Covid-19 infections had in fact occurred as early as October 2019, before its Wuhan discovery in December. Reports of a mysterious pneumonia spreading in Wuhan, China, first emerged in late December 2019. The latest Study expanded on another earlier study by the CDC, there were Covid-19 infections in the US as early as mid-December 2019, weeks before it was first identified in China and a month earlier than the first case was reported in the US on 19 January 2020. The early findings confirmed evidence that the novel coronavirus emerged and was circulating outside of China much earlier than its detection in Wuhan. In the study published in the journal Clinical Infectious Diseases, CDC researchers tested blood samples from 7,389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020, for antibodies specific to the novel Covid-19 coronavirus. The blood tests found Covid-19 antibodies in 106 of 7,389 blood donors, suggesting that they had already been exposed to the virus. The blood samples were from 9 states across the US. Covid-19 antibodies were found in 39 samples from California, Oregon and Washington state collected between 13–16 December 2019, and also in 67 samples in Massachusetts, Michigan, Wisconsin or Iowa, and Connecticut or Rhode Island collected between 30 December 2019 and 17 January 2020. The data indicated that the Covid-19 virus was widespread and isolated in the US much earlier than in Wuhan, China. That means that Americans may have been carrying and spreading the coronavirus while showing only minor symptoms or even no symptoms at all before any infections attributed to Wuhan connections. The latest smoking gun confirms that the Covid-19 coronavirus was already in the US long before China experienced and discovered it in Wuhan, and announced immediately to the world. And within about 100 days, China with a population of 1.3 billion people had managed to contain the pandemic and confine it to just a few cases of daily, mostly imported, infections. On 12 March 2020, CDC Director Robert Redfield admitted to the US Congress’ House Oversight Committee in a statement that some cases in October and November 2019 diagnosed previously as seasonal flu could have been the Covid-19 coronavirus. His statement is corroborated by staunch US allies Japan and Taiwan. Indeed, a 23 February 2020 Japanese Asahi news report claimed that the Covid-19 coronavirus originated in the US, not in China, and that some (or many) of the 14,000 American deaths attributed to influenza may have in fact resulted from the coronavirus. In the United Kingdom (UK), scientists at University College London’s (UCL) Genetics Institute found almost 200 recurrent genetic mutations of the Covid-19 coronavirus which the UCL researchers said showed how it is adapting to its human hosts as it spreads. “Phylogenetic estimates support that the COVID-2 pandemic started sometime around 6 October 2019 to 11 December 2019, which corresponds to the time of the host jump into humans,” the UCL research team, co-led by Francois Balloux, wrote in a study published in the journal Infection, Genetics and Evolution. Other countries have also reported evidence of the Covid-19 virus in 2019 long before its discovery in Wuhan. In France for example, a Covid-19 positive blood sample was taken from a 42-year-old man born in Algeria, who lived in France for many years, and worked as a fishmonger, and whose last overseas trip was to Algeria during August 2019. More importantly, the French Study noted that the man had not been to China, and one of his children had also been sick, the research team reported. Moreover, the absence of a link, directly or indirectly, with China and the lack of recent travel suggest that the disease was already spreading among the French population at the end of December 2019" said the Study. France only reported its first official Covid-19 case on 24 January 2020. Interestingly, in July 2019, the US CDC directed the shutdown of biosafety level 3 and 4 work at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, a US military base, after a failed safety inspection. The USAMRID Fort Dietrich facility is the US Army’s top virus research lab, located in suburban Maryland some 50 miles outside of Washington, DC. Over the past decades, it has conducted leading researches on a wide range of viruses and bacteria inside the sprawling complex. Its state-of-the-art facilities also store some of the most dangerous toxins known to mankind, including Ebola, anthrax and the SARS coronavirus. Some conspiracy theorists allegedly pointed out that “perhaps the US delegates brought the coronavirus to Wuhan during the World Military Games held in Wuhan in October 2019, and some mutation occurred to the virus, making it more deadly and contagious, and causing a widespread Covid-19 pandemic outbreak in 2020”. USAMRIID claimed to be only researching the Ebola virus before the shutdown would appear medium.com Smoking Gun — Covid19 Virus Confirmed in USA Before Wuhan Dr Michael Heng 10-12 minutes China is Definitely Not The Virus Origin Dr Michael Heng Increasingly, more and more studies and evidence are emerging pointing to other Covid-19 virus origins as more plausible or credible alternatives to Wuhan, China, where the virus was first discovered, identified and reported to WHO (World Health Organisation). Scientists are in agreement that the place of first discovery of the virus is not necessarily its origin. The latest smoking gun is provided by the United States United States (US) National Institutes of Health (NIH). The NIH recently published a new study which analyzed more than 24,000 stored blood samples contributed by participants during the January-March 2020 period, and concluded that Covid-19 virus was present in the US as far back as December 2019, weeks before the first officially reported cases, and long before its discovery in Wuhan, China. The scientific study by the US Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America in December 2020 shows that between 13–16 December 2019, coronavirus antibodies were detected in at least 39 blood samples from the states of California, Oregon and Washington. Antibodies are formed by the human body in response to the invasion by foreign viruses. A person’s immune system develops antibodies when exposed to a pathogen like a virus to fight it off. Their presence suggests exposure to a virus. Researchers were looking for antibodies in the blood that represent undisputed evidence of coronavirus infection, and can be detected as early as two weeks after a person is first infected. The researchers say 7 study participants — three from Illinois, and one each from Massachusetts, Mississippi, Pennsylvania, and Wisconsin — were infected earlier than any Covid-19 case was originally reported in those states. They had also considered and dismissed these results to be false positives. Researchers found it noteworthy that the 7 did not live in or near New York City or Seattle, where the first wave of US Covid-19 cases were concentrated. One of the Illinois cases was infected as early as 24 December 2019, indicating that he was likely infected in late November 2019 given the antibody formative period of at least 14 days. Unlike China, and in spite of their capability and capacity in scientific expertise and technology, neither the CDC nor the US government conducted an immediate vigorous and transparent investigation into these earlier cases. The failure to detect the Covid-19 virus earlier in the Fall of 2019 may have cost millions of American lives lost to the virus. Officially, the first US infection to be identified was a traveler — a Washington state man who returned from Wuhan on 15 Jan 2020. The CDC had initially said that this was the spark that started the US Covid-19 outbreak during a 3-week window from 15 January to early February 2020. This is no longer a true and correct assessment. The new Study indicated that “… the Covid-19 virus was probably seeded in multiple places in our country,” said Associate Professor Keri Althoff of the Johns Hopkins Bloomberg School of Public Health and the Study’s lead author. This latest Study adds to numerous earlier research studies — including some done by the CDC — which suggested a small number of Covid-19 infections had in fact occurred as early as October 2019, before its Wuhan discovery in December. Reports of a mysterious pneumonia spreading in Wuhan, China, first emerged in late December 2019. The latest Study expanded on another earlier study by the CDC, there were Covid-19 infections in the US as early as mid-December 2019, weeks before it was first identified in China and a month earlier than the first case was reported in the US on 19 January 2020. The early findings confirmed evidence that the novel coronavirus emerged and was circulating outside of China much earlier than its detection in Wuhan. In the study published in the journal Clinical Infectious Diseases, CDC researchers tested blood samples from 7,389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020, for antibodies specific to the novel Covid-19 coronavirus. The blood tests found Covid-19 antibodies in 106 of 7,389 blood donors, suggesting that they had already been exposed to the virus. The blood samples were from 9 states across the US. Covid-19 antibodies were found in 39 samples from California, Oregon and Washington state collected between 13–16 December 2019, and also in 67 samples in Massachusetts, Michigan, Wisconsin or Iowa, and Connecticut or Rhode Island collected between 30 December 2019 and 17 January 2020. The data indicated that the Covid-19 virus was widespread and isolated in the US much earlier than in Wuhan, China. That means that Americans may have been carrying and spreading the coronavirus while showing only minor symptoms or even no symptoms at all before any infections attributed to Wuhan connections. The latest smoking gun confirms that the Covid-19 coronavirus was already in the US long before China experienced and discovered it in Wuhan, and announced immediately to the world. And within about 100 days, China with a population of 1.3 billion people had managed to contain the pandemic and confine it to just a few cases of daily, mostly imported, infections. On 12 March 2020, CDC Director Robert Redfield admitted to the US Congress’ House Oversight Committee in a statement that some cases in October and November 2019 diagnosed previously as seasonal flu could have been the Covid-19 coronavirus. His statement is corroborated by staunch US allies Japan and Taiwan. Indeed, a 23 February 2020 Japanese Asahi news report claimed that the Covid-19 coronavirus originated in the US, not in China, and that some (or many) of the 14,000 American deaths attributed to influenza may have in fact resulted from the coronavirus. In the United Kingdom (UK), scientists at University College London’s (UCL) Genetics Institute found almost 200 recurrent genetic mutations of the Covid-19 coronavirus which the UCL researchers said showed how it is adapting to its human hosts as it spreads. “Phylogenetic estimates support that the COVID-2 pandemic started sometime around 6 October 2019 to 11 December 2019, which corresponds to the time of the host jump into humans,” the UCL research team, co-led by Francois Balloux, wrote in a study published in the journal Infection, Genetics and Evolution. Other countries have also reported evidence of the Covid-19 virus in 2019 long before its discovery in Wuhan. In France for example, a Covid-19 positive blood sample was taken from a 42-year-old man born in Algeria, who lived in France for many years, and worked as a fishmonger, and whose last overseas trip was to Algeria during August 2019. More importantly, the French Study noted that the man had not been to China, and one of his children had also been sick, the research team reported. Moreover, the absence of a link, directly or indirectly, with China and the lack of recent travel suggest that the disease was already spreading among the French population at the end of December 2019" said the Study. France only reported its first official Covid-19 case on 24 January 2020. Interestingly, in July 2019, the US CDC directed the shutdown of biosafety level 3 and 4 work at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, a US military base, after a failed safety inspection. The USAMRID Fort Dietrich facility is the US Army’s top virus research lab, located in suburban Maryland some 50 miles outside of Washington, DC. Over the past decades, it has conducted leading researches on a wide range of viruses and bacteria inside the sprawling complex. Its state-of-the-art facilities also store some of the most dangerous toxins known to mankind, including Ebola, anthrax and the SARS coronavirus. Some conspiracy theorists allegedly pointed out that “perhaps the US delegates brought the coronavirus to Wuhan during the World Military Games held in Wuhan in October 2019, and some mutation occurred to the virus, making it more deadly and contagious, and causing a widespread Covid-19 pandemic outbreak in 2020”. USAMRIID claimed to be only researching the Ebola virus before the shutdown would appear disingenuous and a lame excuse for its possible role in the Covbid-19 pandemic outbreak in the USA and the world. It is unknown whether any US soldiers from USAMRIID infected with the coronavirus attended the Military World Games held in Wuhan in October 2019. The USAMRIID facility was re-inspected and approved for operations by the CDC in November 2019. It is currently working on the Covid-19 virus, including its replication and purification for future testing. The USAMRIID also “reported” to have received antibodies from someone with Severe Acute Respiratory Syndrome (SARS) which is caused by the SARS-CoV virus, and is genetically similar to the virus that causes COVID-19. According to USAMRIID, it was studying the SARS antibodies to see how they can respond to the Covid-19 virus. They definitely do not. USAMRIID conducted early research on what is now Remdesivir. The drug was originally targeted for Ebola but now being tested as a possible treatment for COVID-19 patients; it was used effectively in an antibody cocktail consisting of Remdesivir, Dexamethasone and Regeneron REGN-COV2 on former US President Trump to successfully treat his coronavirus infection in October 2020 within just 10 months of USAMRIID’s re-opening. Many questions abound. How did USAMRIID know so much about Covid-19 and Remdesivir in order to develop an early effective treatment? Did it have experience with the Covid-19 virus before it was shut down in July 2019? Did any of its people travel to Wuhan for the World Military Games in September 2019, and “inadvertently” introduce or insert the Covid-19 virus into Wuhan? So many unanswered questions, and clearly demanding answers from another WHO investigations. Given the latest smoking gun, the current indisputably clear scientific evidence is the pre-existence of the Covid-19 virus in other countries before it was discovered by the Chinese in Wuhan. The search for the coronavirus origin(s) should now switch to the USA, France, even Spain and Italy, beyond China. Please enjoy my recent Articles disingenuous and a lame excuse for its possible role in the Covbid-19 pandemic outbreak in the USA and the world. It is unknown whether any US soldiers from USAMRIID infected with the coronavirus attended the Military World Games held in Wuhan in October 2019. The USAMRIID facility was re-inspected and approved for operations by the CDC in November 2019. It is currently working on the Covid-19 virus, including its replication and purification for future testing. The USAMRIID also “reported” to have received antibodies from someone with Severe Acute Respiratory Syndrome (SARS) which is caused by the SARS-CoV virus, and is genetically similar to the virus that causes COVID-19. According to USAMRIID, it was studying the SARS antibodies to see how they can respond to the Covid-19 virus. They definitely do not. USAMRIID conducted early research on what is now Remdesivir. The drug was originally targeted for Ebola but now being tested as a possible treatment for COVID-19 patients; it was used effectively in an antibody cocktail consisting of Remdesivir, Dexamethasone and Regeneron REGN-COV2 on former US President Trump to successfully treat his coronavirus infection in October 2020 within just 10 months of USAMRIID’s re-opening. Many questions abound. How did USAMRIID know so much about Covid-19 and Remdesivir in order to develop an early effective treatment? Did it have experience with the Covid-19 virus before it was shut down in July 2019? Did any of its people travel to Wuhan for the World Military Games in September 2019, and “inadvertently” introduce or insert the Covid-19 virus into Wuhan? So many unanswered questions, and clearly demanding answers from another WHO investigations. Given the latest smoking gun, the current indisputably clear scientific evidence is the pre-existence of the Covid-19 virus in other countries before it was discovered by the Chinese in Wuhan. The search for the coronavirus origin(s) should now switch to the USA, France, even Spain and Italy, beyond China. Please enjoy my recent Articles dies are formed by the human body in response to the invasion by foreign viruses. A person’s immune system develops antibodies when exposed to a pathogen like a virus to fight it off. Their presence suggests exposure to a virus. Researchers were looking for antibodies in the blood that represent undisputed evidence of coronavirus infection, and can be detected as early as two weeks after a person is first infected. The researchers say 7 study participants — three from Illinois, and one each from Massachusetts, Mississippi, Pennsylvania, and Wisconsin — were infected earlier than any Covid-19 case was originally reported in those states. They had also considered and dismissed these results to be false positives. Researchers found it noteworthy that the 7 did not live in or near New York City or Seattle, where the first wave of US Covid-19 cases were concentrated. One of the Illinois cases was infected as early as 24 December 2019, indicating that he was likely infected in late November 2019 given the antibody formative period of at least 14 days. Unlike China, and in spite of their capability and capacity in scientific expertise and technology, neither the CDC nor the US government conducted an immediate vigorous and transparent investigation into these earlier cases. The failure to detect the Covid-19 virus earlier in the Fall of 2019 may have cost millions of American lives lost to the virus. Officially, the first US infection to be identified was a traveler — a Washington state man who returned from Wuhan on 15 Jan 2020. The CDC had initially said that this was the spark that started the US Covid-19 outbreak during a 3-week window from 15 January to early February 2020. This is no longer a true and correct assessment. The new Study indicated that “… the Covid-19 virus was probably seeded in multiple places in our country,” said Associate Professor Keri Althoff of the Johns Hopkins Bloomberg School of Public Health and the Study’s lead author. This latest Study adds to numerous earlier research studies — including some done by the CDC — which suggested a small number of Covid-19 infections had in fact occurred as early as October 2019, before its Wuhan discovery in December. Reports of a mysterious pneumonia spreading in Wuhan, China, first emerged in late December 2019. The latest Study expanded on another earlier study by the CDC, there were Covid-19 infections in the US as early as mid-December 2019, weeks before it was first identified in China and a month earlier than the first case was reported in the US on 19 January 2020. The early findings confirmed evidence that the novel coronavirus emerged and was circulating outside of China much earlier than its detection in Wuhan. In the study published in the journal Clinical Infectious Diseases, CDC researchers tested blood samples from 7,389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020, for antibodies specific to the novel Covid-19 coronavirus. The blood tests found Covid-19 antibodies in 106 of 7,389 blood donors, suggesting that they had already been exposed to the virus. The blood samples were from 9 states across the US. Covid-19 antibodies were found in 39 samples from California, Oregon and Washington state collected between 13–16 December 2019, and also in 67 samples in Massachusetts, Michigan, Wisconsin or Iowa, and Connecticut or Rhode Island collected between 30 December 2019 and 17 January 2020. The data indicated that the Covid-19 virus was widespread and isolated in the US much earlier than in Wuhan, China. That means that Americans may have been carrying and spreading the coronavirus while showing only minor symptoms or even no symptoms at all before any infections attributed to Wuhan connections. The latest smoking gun confirms that the Covid-19 coronavirus was already in the US long before China experienced and discovered it in Wuhan, and announced immediately to the world. And within about 100 days, China with a population of 1.3 billion people had managed to contain the pandemic and confine it to just a few cases of daily, mostly imported, infections.